Related Experiment Video
Updated: Oct 26, 2025
Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo
Published on: February 6, 2015
The potential use of simvastatin for cancer treatment: A review
Jaqueline Aparecida Duarte1, Andre Luis Branco de Barros2, Elaine Amaral Leite1
1Department of Pharmaceutical Products, Faculty of Pharmacy, Federal University of Minas Gerais, Av. Antônio Carlos, 6627, 31270-901 Belo Horizonte, Minas Gerais, Brazil.
Abstract:
Statins, typically used to reduce lipid levels, have been rediscovered for exhibiting anticancer activities. Among them, especially simvastatin may influence the proliferation, migration, and survival of cancer cells. The concept of using statins to treat cancer has been adopted since the 1990s In vitro and in vivo experiments and cohort studies using statins have been carried out to demonstrate their antitumor effects (such as proliferation and migration impairment) by influencing inflammatory and oxidative stress-related tumorigenesis. Nevertheless, the biological mechanisms for these actions are not fully elucidated. In this review, we present an overview of the most important studies conducted from 2015 to date on the use of simvastatin in cancer therapy. This review brings the most recent perspectives and targets in epidemiological, in vitro, and in vivo studies, regarding the use of simvastatin alone or in combination with other drugs for the treatment of various types of cancer.
Insights
Simvastatin, a cholesterol-lowering drug, shows promise as an anticancer agent by affecting cancer cell growth and survival. Recent studies explore its therapeutic potential alone or with other drugs for various cancers.
Area of Science:
- Oncology
- Pharmacology
- Biochemistry
Background:
- Statins, primarily lipid-lowering drugs, possess rediscovered anticancer properties.
- Simvastatin, in particular, impacts cancer cell proliferation, migration, and survival.
- The use of statins in cancer therapy has been explored since the 1990s, with evidence from in vitro, in vivo, and cohort studies.
Purpose of the Study:
- To review recent studies (2015-present) on simvastatin's role in cancer therapy.
- To highlight current perspectives and therapeutic targets for simvastatin in cancer treatment.
- To consolidate findings on simvastatin's efficacy as a monotherapy or in combination treatments.
Main Methods:
- Review of epidemiological studies.
- Analysis of in vitro experiments.
- Evaluation of in vivo studies and clinical data.
Main Results:
- Simvastatin demonstrates antitumor effects, including impaired proliferation and migration.
- Evidence suggests simvastatin influences inflammatory and oxidative stress pathways in tumorigenesis.
- Studies investigate simvastatin's potential in various cancer types, both alone and in combination therapies.
Conclusions:
- Simvastatin presents a viable therapeutic option for cancer treatment.
- Further research is needed to fully elucidate the biological mechanisms of simvastatin's anticancer effects.
- Simvastatin holds promise for novel cancer treatment strategies, particularly in combination therapies.
More Related Videos
09:34Uptake of New Lipid-coated Nanoparticles Containing Falcarindiol by Human Mesenchymal Stem Cells
Published on: February 9, 2019
09:20Preclinical Assessment of the Bioactivity of the Anticancer Coumarin OT48 by Spheroids, Colony Formation Assays, and Zebrafish Xenografts
Published on: June 26, 2018